Retraction Note: J Exp Clin Cancer Res 39, 116 (2020)
https://doi.org/10.1186/s13046-020-01606-x
The Editor-in-Chief has retracted this article because of the following concerns:
-
Within Figure 3D, the panels (OS-RC-2 vs sh-CCDC50#1) and (OS-RC-2 vs sh-CCDC50#2) overlap.
-
Figure 3H contained a panel (CCDC50-S vs whole) with missing sections within the image.
-
An incorrect panel (OS-RC-2 vs sh-HnRNP A1+CCDC50-FL) was provided for supplementary figure 5B.
The data reported in this article are therefore unreliable.
Guoliang Sun and Hua Xu agree to this retraction. Hui Zhou has agreed to this retraction but not to the wording of this retraction notice. Ke Chen, Jin Zeng, Yangjun Zhang, Libin Yan, Weimin Yao, Junhui Hu, Tao Wang, Jinchun Xing, Kefeng Xiao, Lily Wu and Zhangqun Ye have not responded to any correspondence from the publisher about this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sun, G., Zhou, H., Chen, K. et al. Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395. J Exp Clin Cancer Res 42, 43 (2023). https://doi.org/10.1186/s13046-023-02613-4
Published:
DOI: https://doi.org/10.1186/s13046-023-02613-4